U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT07519577) titled 'A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis （NEZHA-2）' on April 02.
Brief Summary: This is an open-label, single-arm, multicenter, expansion study to evaluate the safety and efficacy of CM512 in patients With Chronic Rhinosinusitis with Nasal Polyposis
Study Start Date: May 31
Study Type: INTERVENTIONAL
Condition:
Chronic Rhinosinusitis With Nasal Polyposis
Intervention:
BIOLOGICAL: CM512
Administered subcutaneous injection
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Keymed Biosciences Co.Ltd
Published by HT Digital Content Services with permission from Health Daily Dige...